V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016543 | 160008200 | 0 | 11.5 | Curative (C) | 2019-01-26 | 2019-02-02 | Carboplatin + Liposomal Doxorubicin | 02 | N | LIPOSOMAL DOXORUBICIN | 100687076 |
| 160016547 | 160008201 | 1.55 | 70 | Neo-adjuvant (N) | 2018-06-28 | 2018-06-28 | Doxorubicin + Olaratumab | N | N | DOXORUBICIN + IFOSFAMIDE | 100387025 |
| 160016548 | 160008202 | 0 | 0 | Palliative (P) | 2017-06-19 | 2017-06-29 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101800682 |
| 160016550 | 160008203 | null | 13.9 | Palliative (P) | 2018-10-09 | 2018-10-22 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101309547 |
| 160016552 | 160008204 | 1.7 | 80.4 | Palliative (P) | 2019-02-20 | 2019-03-12 | Carboplatin AUC 6 - 10 | N | N | CARBOPLATIN | 100726013 |
| 160016557 | 160008205 | 1.74 | 90.7 | Palliative (P) | 2016-04-22 | 2016-05-02 | DOXORUBICIN | N | N | CARBOPLATIN | 100069644 |
| 160016558 | 160008206 | null | null | Palliative (P) | 2020-02-18 | 2020-02-20 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101357201 |
| 160016560 | 160008207 | 1.75 | 58.6 | Palliative (P) | null | 2017-03-18 | NB HRNBL-1 MOD N7 CAV | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101111444 |
| 160016562 | 160008208 | 0 | 35.1 | Palliative (P) | 2019-02-28 | 2019-03-15 | Pemetrexed | 02 | N | CARBOPLATIN + PACLITAXEL | 100895540 |
| 160016563 | 160008209 | 1.73 | 76.7 | Palliative (P) | 2016-06-17 | 2016-06-17 | Doxorubicin + Ifosfamide | 02 | N | IFOSFAMIDE + LIPOSOMAL DOXORUBICIN | 100313518 |
| 160016564 | 160008210 | 1.84 | 66 | Palliative (P) | 2019-12-26 | 2020-01-01 | DOXORUBICIN | 02 | N | TRIAL | 100599975 |
| 160016566 | 160008211 | 1.78 | 82 | null | 2018-07-07 | 2018-07-15 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100714402 |
| 160016568 | 160008212 | 1.68 | 68 | null | 2017-08-26 | 2017-09-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100064632 |
| 160016570 | 160008213 | 1.82 | 10.4 | Palliative (P) | 2016-12-07 | 2016-12-14 | Vinorelbine (oral) | 02 | null | DOCETAXEL + GEMCITABINE | 100711765 |
| 160016572 | 160008214 | 1.86 | 73.7 | null | 2016-10-08 | 2016-10-25 | DOXORUBICIN | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101496620 |
| 160016573 | 160008215 | 1.61 | 54.7 | Palliative (P) | null | 2019-10-27 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100506796 |
| 160016574 | 160008216 | 1.52 | 67.2 | Neo-adjuvant (N) | 2013-10-13 | 2016-05-14 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101430989 |
| 160016575 | 160008217 | 1.77 | 53.6 | 03 | 2015-11-28 | 2015-11-30 | CONFIRM TRIAL | 02 | N | IDARUBICIN | 100130541 |
| 160016576 | 160008218 | 1.82 | 99.1 | 03 | 2019-12-24 | 2020-01-23 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101269451 |
| 160016580 | 160008219 | null | 77 | Palliative (P) | 2016-10-12 | 2016-10-12 | VINORELBINE | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100179383 |
| 160016581 | 160008220 | 1.7 | 81 | Palliative (P) | 2016-11-17 | 2016-12-29 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101110125 |
| 160016583 | 160008221 | 1.75 | 97 | Palliative (P) | 2019-10-21 | 2019-10-21 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101370304 |
| 160016584 | 160008222 | 1.69 | 95.75 | Neo-adjuvant (N) | 2020-01-11 | 2020-01-19 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100622382 |
| 160016585 | 160008223 | 1.76 | 75 | Neo-adjuvant (N) | 2017-04-22 | 2017-05-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100061385 |
| 160016587 | 160008224 | 1.7 | 67.5 | Palliative (P) | 2020-04-03 | 2020-04-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN | 101439690 |
| 160016588 | 160008225 | 1.72 | 82.9 | Curative (C) | null | 2020-09-04 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100516673 |
| 160016589 | 160008226 | 1.8 | 91.75 | Curative (C) | 2021-12-25 | 2021-12-25 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | BEP | 100705812 |
| 160016590 | 160008227 | 1.56 | 80.6 | Palliative (P) | 2019-02-07 | 2019-02-28 | Doxorubicin + Ifosfamide | N | N | BEVACIZUMAB | 100817194 |
| 160016592 | 160008229 | null | null | Palliative (P) | 2019-01-22 | 2019-02-20 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 101336104 |
| 160016594 | 160008230 | 1.62 | 67.8 | Palliative (P) | 2018-12-20 | 2018-12-20 | EW EuroEwing 2012 Arm A VIDE | 02 | N | RMS 2005 TRIAL | 100251201 |
| 160016596 | 160008231 | 1.89 | 111.4 | Adjuvant (A) | 2019-09-15 | 2019-09-19 | Doxorubicin + Olaratumab | 02 | N | PEMBROLIZUMAB | 101238130 |
| 160016597 | 160008232 | 1.78 | 80.9 | Palliative (P) | 2018-05-02 | 2018-05-21 | Trial Unspecified | 02 | N | CARBOPLATIN | 101291739 |
| 160016598 | 160008233 | 1.78 | 60 | Palliative (P) | 2018-03-18 | 2018-03-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101377863 |
| 160016600 | 160008234 | null | 84.7 | 03 | 2019-12-06 | 2019-12-14 | Liposomal Doxorubicin (Caelyx) | Y | N | EW EUROEWING 2012 ARM B VDC | 100627325 |
| 160016601 | 160008235 | 1.8 | 77.4 | Palliative (P) | 2017-05-15 | 2017-05-29 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101288706 |
| 160016603 | 160008236 | 1.6 | 59 | Curative (C) | null | 2019-09-01 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100769340 |
| 160016606 | 160008237 | 1.78 | 80.9 | 03 | 2018-09-02 | 2018-09-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100135342 |
| 160016613 | 160008238 | 1.78 | 87 | Neo-adjuvant (N) | 2017-03-22 | 2017-04-01 | Cyclophosphamide + Vincristine | Y | N | TRIAL | 101487963 |
| 160016614 | 160008239 | 1.56 | 92.3 | Palliative (P) | 2016-05-31 | 2016-06-14 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101439583 |
| 160016624 | 160008240 | 1.94 | 69.5 | Palliative (P) | 2017-04-11 | 2017-04-15 | Doxorubicin + Olaratumab | 02 | Y | BEVACIZUMAB | 100967509 |
| 160016625 | 160008241 | 1.51 | 71.6 | Palliative (P) | 2017-11-25 | 2017-11-25 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101559957 |
| 160016626 | 160008242 | 1.86 | 91 | Neo-adjuvant (N) | 2018-01-15 | 2018-01-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100576484 |
| 160016631 | 160008243 | 1.59 | 70.9 | Palliative (P) | 2016-10-10 | 2016-10-10 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100602223 |
| 160016632 | 160008244 | 1.58 | 60.9 | Palliative (P) | 2016-10-26 | 2016-10-26 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101669758 |
| 160016633 | 160008245 | null | 88 | Palliative (P) | 2017-03-15 | 2017-03-15 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100365737 |
| 160016634 | 160008246 | 1.74 | 65.4 | Curative (C) | 2018-06-15 | 2018-06-18 | Ifosfamide PVI 1g/m2 14day | Y | N | TRABECTEDIN | 101340491 |
| 160016636 | 160008247 | 1.84 | 52.4 | Palliative (P) | 2019-11-01 | 2019-11-08 | DOXORUBICIN | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100921383 |
| 160016638 | 160008248 | 0 | 10 | Curative (C) | 2019-11-24 | 2019-12-14 | Doxorubicin + Ifosfamide | N | N | DOXORUBICIN + OLARATUMAB | 101713676 |
| 160016639 | 160008249 | 1.55 | 107.6 | Palliative (P) | 2019-11-16 | 2019-11-19 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100396385 |
| 160016640 | 160008250 | 1.48 | 49.15 | Curative (C) | 2017-10-13 | 2017-10-20 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100225927 |